of disease. The patient has no symptoms of disease, normal lab evaluations, and was working full-time until the COVID-19 pandemic. Case 2 was of a 51-year-old man with gross hematuria seen in September 2018. Initial management at that time was
Search Results
Presenters: Chad A. LaGrange, M. Dror Michaelson, and Colleen H. Tetzlaff
Presenters: Mazyar Shadman and Deborah M. Stephens
to flow cytometry for MRD testing,” he added. All 3 doctors agreed that the COVID-19 pandemic is shifting their thinking favoring small molecule inhibitors. “In this current situation we want to preserve immune function and try not to choose a therapy
Ivan Lolli, Anna Maria Valentini, Angela Dalia Ricci, and Raffaele Armentano
treatment for this patient with physical disability due to previous limb amputation was started and conducted during the second wave of the COVID-19 pandemic. Within that period, oncology activities were severely endangered by this infectious threat, and
Jennifer Barsky Reese, Lauren A. Zimmaro, Sharon L. Bober, Kristen Sorice, Elizabeth Handorf, Elaine Wittenberg, Areej El-Jawahri, Mary Catherine Beach, Antonio C. Wolff, Mary B. Daly, Brynna Izquierdo, and Stephen J. Lepore
These rates were noteworthy in light of the time commitment being asked of the clinicians (ie, 2 half-hour podcasts, 3 study surveys) and the fact that the bulk of enrollment occurred during the COVID-19 pandemic and the ensuing societal and professional
Rongbo Lin, Sunzhi Lin, Shuitu Feng, Qingyi Wu, Jianqian Fu, Fang Wang, Hui Li, Xiaofeng Li, Gaowang Zhang, Yongzhi Yao, Min Xin, Tianyang Lai, Xia Lv, Yigui Chen, Shangwang Yang, Yubiao Lin, Lixia Hong, Zhenyu Cai, Jianfeng Wang, Gen Lin, Shaowei Lin, Shen Zhao, Jinfeng Zhu, and Cheng Huang
providers and resources, which may be of particular importance during times of medical crisis, such as the COVID-19 pandemic. To our knowledge, this is the first study to provide high-level evidence for PCA-based intravenous opioid titration as a viable
Owen Tan, Deborah J. Schofield, and Rupendra Shrestha
strategy . Med J Aust 2019 ; 210 : 202 – 203.e1 . 10.5694/mja2.50041 41. Fisk M , Livingstone A , Pit SW . Telehealth in the context of COVID-19: changing perspectives in Australia, the United Kingdom, and the United States . J Med
Linda Watson, Siwei Qi, Claire Link, Andrea DeIure, Arfan Afzal, and Lisa Barbera
, Virtual cancer care during the COVID-19 pandemic in Alberta: evidence from a mixed methods evaluation and key learnings . JCO Oncol Pract 2021 ; 17 : e1354 – 1361 . 34351822 44. Bubis LD , Davis L , Mahar A , Symptom burden in the
Yuqi Zhang, Marcelo Cerullo, Andrew Esposito, and Vishnukamal Golla
as sources of health care cost data . Med Care 2009 ; 47 ( Suppl 1 ): S51 – 55 . 10.1097/MLR.0b013e31819c95aa 19536019 48. Cutler DM , Summers LH . The COVID-19 pandemic and the $16 trillion virus . JAMA 2020 ; 324 : 1495 – 1496
Mostafa R. Mohamed, Kah Poh Loh, Supriya G. Mohile, Michael Sohn, Tracy Webb, Megan Wells, Sule Yilmaz, Rachael Tylock, Eva Culakova, Allison Magnuson, Can-Lan Sun, James Bearden, Judith O. Hopkins, Bryan A. Faller, and Heidi D. Klepin
, Predictors of hospitalization among older adults with COVID-19 in Saudi Arabia: a cross-sectional study of a nationally representative sample . Risk Manag Healthc Policy 2021 ; 14 : 875 – 886 . 33692640 17. Marcusson J , Nord M , Dong HJ
Yujiao Sun, Adam Hendrix, Benyam Muluneh, and Sachiko Ozawa
2022 ; 24 : e25855 . 35156937 10.2196/25855 31. Ozawa S , Billings J , Sun Y , COVID-19 treatments sold online without prescription requirements in the United States: cross-sectional study evaluating availability, safety, and
